UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549


                            FORM 10-Q

   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
July 31, 2000                          Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At  July  31,  2000,  22,009,149 shares of common  stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                   Quarter Ended July 31, 2000


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statements of Earnings for the three months
           ended July 31, 2000 and 1999                      2

           Balance Sheets at July 31, 2000 and
           April 30, 2000                                  3-4

           Statements of Cash Flows for the three months
           ended July 31, 2000 and 1999                      5

           Notes to Financial Statements                     6

           Independent Accountants' Report                  10

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations    11

  Item 3. Quantitative and Qualitative Disclosures About
           Market Risk                                      15

Part II - Other Information

  Item 4. Submission of Matters to a Vote of Security
           Holders                                          15

  Item 5. Other Information                                 15

  Item 6. Exhibits and Reports on Form 8-K                  16


Signature                                                   17

Exhibit Index                                               18

<PAGE 2>

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                             Three Months
In thousands (except per share amounts)     Ended July 31,
--------------------------------------------------------------
                                           2000       1999
                                        ----------------------
Revenue:

  Product sales                        $125,958     $125,856
  Service                                12,432       13,620
                                       --------     --------
                                        138,390      139,476
                                       --------     --------

Costs and Expenses:

  Cost of product sales                  81,103       72,621
  Cost of service                         8,398        7,305
  Selling, general and administrative    35,923       35,092
  Research and development expenses       7,755        8,598
  Goodwill amortization                   2,241        2,136
  Special charge (Note 3)                 4,419           --
                                       --------     --------
                                        139,839      125,752
                                       --------     --------

Operating income (loss)                  (1,449)      13,724

Other income                                540          393
Interest expense                         (3,286)      (2,464)
                                       --------     --------

Earnings (loss) before income taxes      (4,195)      11,653

Provision (benefit) for income taxes     (1,500)       4,100
                                       --------     --------

Net earnings (loss)                     ($2,695)    $  7,553
                                        ========    ========
Per share of common stock:
  Basic                                 ($  .12)    $    .34
  Diluted                               ($  .12)    $    .34

  Dividends                              $  .08     $    .08

Average shares outstanding:
  Basic                                  21,998       22,118
  Diluted                                21,998       22,452

                     See Accompanying Notes

<PAGE 3-4>

             GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS


---------------------------------------------------------------
                                          July 31,   April 30,
In thousands                               2000         2000
---------------------------------------------------------------
Assets
Current Assets:
 Cash and short-term cash investments     $ 18,406     $ 22,954
 Accounts receivable                       105,497      121,494
 Inventories                                90,075       86,472
 Prepaid expenses                           22,490       21,042
                                          --------     --------
                                           236,468      251,962
                                          --------     --------
Property, Plant and Equipment              170,237      165,341
 Less accumulated depreciation              69,672       66,121
                                          --------     --------
                                           100,565       99,220
                                          --------     --------

Intangible Assets                          246,125      245,797
 Less accumulated amortization              29,930       27,419
                                          --------     --------
                                           216,195      218,378
                                          --------     --------
Other Assets                                 3,534        3,276
                                          --------     --------
                                          $556,762     $572,836
                                          ========     ========
Liabilities and Shareholders' Equity

Current Liabilities:
 Notes payable                            $     --     $     --
 Accounts payable                           52,428       58,043
 Accrued compensation and benefits          12,730       16,646
 Other accrued liabilities                  28,882       26,689
 Deferred revenue                            7,911        8,436
 Advances on sales contracts                 3,079        2,610
                                          --------     --------
                                           105,030      112,424
                                          --------     --------
Noncurrent Liabilities:
 Deferred income taxes                       7,979        8,608
 Long-term debt                            190,880      194,892
                                          --------     --------
                                           198,859      203,500
                                          --------     --------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares; no
  shares issued                                --           --
 Common stock, $1 par value;
  authorized 65,000,000 shares; issued
  22,804,311 and 22,779,651 shares         22,804       22,780
 Paid-in capital                           43,837       43,615
 Retained earnings                        206,296      210,749
 Treasury stock, at cost (795,162 and
  797,444 shares, respectively)           (16,351)     (16,397)
 Unamortized value of restricted stock
  grants                                     (649)        (557)
 Accum. other comprehensive income (loss)  (3,064)      (3,278)
                                          -------     --------
                                          252,873      256,912
                                          -------     --------
                                         $556,762     $572,836
                                         ========     ========


                     See Accompanying Notes

<PAGE 5>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF CASH FLOWS
---------------------------------------------------------------------
                                                     Three Months
In thousands                                         Ended July 31,
---------------------------------------------------------------------
                                                  2000         1999
                                               ----------------------
Cash Provided by (Used for):
Operating Activities:
  Net earnings (loss)                           ($2,695)    $  7,553
  Adjustments to reconcile net earnings to
   cash provided by operating activities:
     Depreciation and amortization                6,908        6,096
     Special charge                               4,419           --
     Deferred income taxes                         (629)         249
     Other non-cash items                           127           76
     Changes in operating accounts:
      Receivables                                15,997       (5,270)
      Inventories                                (3,603)     (10,499)
      Prepaid expenses                           (1,448)       6,565
      Accounts payable and accrued expenses     (10,905)      (6,845)
                                                -------     --------
Provided by (Used for) Operating Activities       8,171       (2,075)
                                                -------     --------
Investing Activities:
  Additions to property, plant and equipment     (6,559)      (5,069)
  Intangible and other assets                      (677)           8
  Other, net                                        214          590
                                                -------     --------
(Used for) Investing Activities                  (7,022)      (4,471)
                                                -------     --------
Financing Activities:
  Additions of long-term debt                    13,000       10,606
  Repayments of long-term debt                  (17,012)     (13,097)
  Proceeds from issuance of stock                    73        1,765
  Dividends on common stock                      (1,758)      (1,765)
                                                --------    --------
(Used for) Financing Activities                  (5,697)      (2,491)
                                                --------    --------

(Decrease) in Cash and Short-Term
  Cash Investments                               (4,548)      (9,037)

Cash and Short-Term Cash Investments,
  Beginning of Period                            22,954       26,523
                                                -------     --------

Cash and Short-Term Cash Investments,           $18,406     $ 17,486
  End of Period                                 =======     ========
                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
     NOTES TO (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. Basis of Presentation

The accompanying unaudited consolidated financial statements have
been  prepared  in accordance with generally accepted  accounting
principles  for  interim  financial  statements  and   with   the
instructions  to  Form  10-Q and Article 10  of  Regulation  S-X.
Accordingly,  they  do  not include all of  the  information  and
footnotes  required  by generally accepted accounting  principles
for complete financial statements.  In the opinion of management,
all   adjustments  (consisting  of  normal  recurring   accruals)
considered necessary for a fair presentation have been  included.
Operating results for the three-month period ended July 31,  2000
are  not  necessarily  indicative of  the  results  that  may  be
expected for the year ended April 30, 2001.

For  further  information,  refer to the  consolidated  financial
statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 2000.

NOTE 2. Inventories

The classification of inventories was as follows (in thousands):

                                  July 31, 2000  April 30, 2000
                                  -------------  --------------
Raw materials and purchased parts    $57,146         $52,847
Work in process                       32,929          33,625
                                     -------         -------
                                     $90,075         $86,472
                                     =======         =======

NOTE 3. Special Charge

In  June  2000, the Company began implementation of a program  to
reduce the number of employees by approximately 7.5 percent (225-
240   people)  through  early  retirement  incentives,  voluntary
separation   arrangements,   and  involuntary   severance.    The
workforce  reductions  primarily  affect  the  Sign  Making   and
Specialty  Graphics and Apparel and Flexible Materials  operating
segments.   The  Company recorded a special charge that  included
$1.9  million of provisions for employee termination benefits  in
the  first  quarter of 2000. Approximately $0.6  million,  or  37
percent of the accrual for the program, had been paid as of  July
31, 2000.

The  special  charge  also  included provisions  for  anticipated
losses  on  the sale of facilities amounting to $2.3 million  and
losses  for other impaired assets, principally patents, amounting
to $0.2 million.  The facilities, with a carrying value of $5.7
million after the provision, are not occupied and the expected
disposal dates are uncertain at this time.

<PAGE 7>

The  above actions totaled $4.4 million and are included  in  the
line "special charge" in the consolidated statement of earnings.

NOTE 4. Segment Information
                                         Three Months Ended
In thousands                                  July 31,
--------------------------------    -----------------------------
                                        2000            1999
                                    -------------   -------------
Segment revenue:
 Sign Making & Specialty Graphics       $ 68,853         $ 68,334
 Apparel & Flexible Materials             46,887           48,865
 Ophthalmic Lens Processing               22,650           22,277
                                        --------         --------
                                        $138,390         $139,476
                                        ========         ========
Segment profit:
 Sign Making & Specialty Graphics       $  2,855         $  8,866
 Apparel & Flexible Materials               (147)           5,144
 Ophthalmic Lens Processing                  840            1,251
                                        --------         --------
                                        $  3,548         $ 15,261
                                        ========         ========

A  reconciliation  of  total  segment  profits  to  consolidated
earnings before income taxes is as follows:

                                         Three Months Ended
In thousands                                  July 31,
--------------------------------     ---------------------------
                                         2000           1999
                                      ------------  ------------
Segment profit                            $ 3,548      $ 15,261
Corporate expenses,  net   of
 other income/expense                      (4,457)       (1,144)
                                         --------      --------
Earnings (loss) before interest and
 taxes                                       (909)       14,117
Interest expense                           (3,286)       (2,464)
                                         --------      --------
Earnings (loss) before income taxes      ($ 4,195)     $ 11,653
                                         ========      ========

There were no material changes in segment assets, the measure of
segment  profit,  or  differences in the basis  of  segmentation
since the Company's last Annual Report on Form 10-K.

<PAGE 8>

NOTE 5. Comprehensive Income

The  Company's  total comprehensive income  was  as  follows  (in
thousands):

                                             Three Months Ended
                                                  July 31,
                                             -------------------
                                              2000      1999
                                             --------  --------
Net income (loss)                           ($2,695)    $7,553
Other comprehensive income (loss):
  Foreign currency translation adjustments      214       (565)
                                             ------     ------
  Total comprehensive income (loss)         ($2,481)    $6,988
                                             ======     ======


NOTE 6. Earnings Per Share

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share for the periods indicated:

                                          Three Months Ended
                                               July 31,
                                        ------------------------
                                          2000          1999
                                        ----------    ----------
Numerator:
 Net income (loss)                    ($2,695,000)   $ 7,553,000
                                       ===========   ===========
Denominators:
 Denominator for basic earnings per
 share-
  weighted-average shares
  outstanding                          21,997,623     22,118,027

 Effect of dilutive securities:
  Stock options                                --        333,782
                                      -----------    -----------
  Denominator for diluted earnings
  per share-
   adjusted weighted-average
   shares outstanding                  21,997,623     22,451,809
                                      ===========    ===========
Basic earnings (loss) per share       $     (.12)    $       .34
                                      ===========    ===========
Diluted earnings (loss) per share     $     (.12)    $       .34
                                      ===========    ===========
For the quarter ended July 31, 2000, there were 2,294 shares of
common stock equivalents that were not included in the calculation
of diluted EPS above because they were antidilutive.

<PAGE 9>

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES




With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at July 31, 2000 and
for  the  three-month periods ended July 31, 2000 and 1999,  KPMG
LLP  has  made  a  review  (based on procedures  adopted  by  the
American  Institute of Certified Public Accountants) and  not  an
audit,  as  set forth in their separate report dated  August  16,
2000  appearing  on  page 10.  That report does  not  express  an
opinion   on   the   interim  unaudited  consolidated   financial
information.   KPMG  LLP has not carried out any  significant  or
additional  audit  tests  beyond  those  which  would  have  been
necessary  if  their report had not been included.   Accordingly,
such  report  is  not  a "report" or "part  of  the  Registration
Statement"  within  the  meaning of Sections  7  and  11  of  the
Securities Act of 1933 and the liability provisions of Section 11
of such Act do not apply.


<PAGE 10>

                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
and  cash  flows of Gerber Scientific, Inc. and subsidiaries  for
the  three-month  periods ended July 31, 2000 and  1999  and  the
consolidated balance sheet as of July 31, 2000 in accordance with
standards  established  by the American  Institute  of  Certified
Public  Accountants.  We have previously audited,  in  accordance
with  generally  accepted auditing standards, and  expressed  our
unqualified  opinion  dated  May 24,  2000  on  the  consolidated
financial  statements  for the year ended  April  30,  2000  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings and cash flows for the three-
month  periods  ended July 31, 2000 and 1999 or the  consolidated
balance  sheet  as of July 31, 2000 for them to be in  conformity
with  generally  accepted  accounting principles.  Also,  in  our
opinion  the information in the accompanying consolidated balance
sheet  as  of April 30, 2000 is fairly presented, in all material
respects,  in  relation to the consolidated  balance  sheet  from
which it has been derived.




/s/ KPMG LLP


Hartford, Connecticut
August 16, 2000


<PAGE 11>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.3  to  1  at July 31, 2000 compared with 2.2 to 1 at April  30,
2000.  Net working capital at July 31, 2000 was $131.4 million, a
decrease of $8.1 million from the beginning of the current fiscal
year  and  largely  attributable  to  lower  accounts  receivable
balances  resulting from concerted efforts to accelerate customer
collections.

The  Company's  cash  and investments totaled  $18.4  million  at
July 31, 2000 compared with $23.0 million at the end of the prior
fiscal year.  Operating activities generated $8.2 million in cash
for the three-month period ended July 31, 2000 compared with $2.1
million  used  by operating activities for the same  period  last
year.   Higher inventory balances partially offset cash generated
by   earnings,   the   non-cash  charges  for  depreciation   and
amortization, and the lower accounts receivable balances in  this
year's  first  three months. Lower accounts payable  and  accrued
liability  balances, due largely to the timing of payments,  were
also offsets to cash generation in the first quarter.

The principal non-operating use of cash in the three months ended
July 31, 2000 was for additions to property, plant, and equipment
of   $6.6   million.   The  Company  anticipates   that   capital
expenditures for the current fiscal year will be in the range  of
$18 - $20 million and expects to fund these with cash on hand and
cash  from  operations.   Cash  was  also  used  for  payment  of
dividends of $1.8 million in the first quarter.

The  Company's total long-term debt at July 31, 2000  was  $190.9
million,  down from the April 30, 2000 balance of $194.9 million.
The  ratio  of  total debt to EBITDA (earnings  before  interest,
taxes,  depreciation, and amortization) increased as of July  31,
2000  and  this  will  cause  interest  rates  on  the  Company's
borrowings  under its syndicated bank lines to  increase  in  the
future.  This is discussed further under "Results of Operations."
Net  debt  (total  debt  less cash and  investments)  was  $172.5
million at July 31, 2000 versus $171.9 million at April 30,  2000
and the ratio of net debt to total capital increased slightly  to
40.5  percent  at July 31, 2000 from 40.1 percent  at  April  30,
2000.

RESULTS OF OPERATIONS

Combined  sales  and  service revenue for the three-month  period
ended  July  31, 2000 was $138.4 million, which was $1.1  million
(0.8  percent)  lower than the first quarter of last  year.   The
decrease  reflected product sales that were roughly the  same  as
the prior year and service revenue that was lower.  Product sales
revenue was suppressed approximately $6.6 million in this  year's

<PAGE 12>

first   quarter  by  comparatively  weaker  European  currencies.
Product  sales in each segment were also pressured by  relatively
weaker demand for equipment in North American markets, and in the
Company's  Sign  Making  and Specialty  Graphics  segment,  by  a
transition  of  distributors  from an  incentive-based  inventory
stocking  model  to a demand-pull distribution model.  Businesses
that  were  acquired in the prior year generated $6.2 million  in
sales in this year's first quarter and helped offset some of  the
year-to-year  sales  shortfall.  Service revenue  decreased  $1.2
million  (8.7 percent) from the first quarter of last year.   The
decrease occurred primarily in the Apparel and Flexible Materials
operating  segment  and resulted from the translation  effect  on
service revenue earned in weaker European currencies and the loss
of  service  business  in North America.  The  decline  in  North
American  service is coincident with the continuing migration  of
the apparel industry to offshore locales.

The  consolidated gross profit margin in this year's first  three
months  was 35.3 percent, which was significantly lower than  the
prior year margin of 42.7 percent.  Gross profit margins on  both
product  sales and service revenue were lower.  The  decrease  in
product gross profit margins was the result of a shift in mix  on
both  a  product  and  geographic basis and also  the  impact  of
lowered  European  currency values which are compressing  margins
and   impacting  price  competitiveness.   From  a  business  mix
perspective, equipment sales slipped to under 40 percent  of  the
Company's   total  sales  and  within  this  category,   hardware
equipment   sales   were   higher  and   software   sales   (with
comparatively higher margins) were lower than the prior year.  On
a  geographic  basis,  the  increase in  sales  in  international
markets  and the softness in the North American equipment  market
had  negative gross margin implications in the quarter. Sales  in
North  America  are generally the Company's most  profitable  and
international  markets the least profitable  as  these  sales  go
through   the  Company's  independent  distribution  and   agency
network.    The  continued  deterioration  of  European  currency
valuations  further  eroded gross profit margins,  reducing  them
$1.5  million from the prior year and occurring primarily in  the
Sign  Making  and  Specialty Graphics and  Apparel  and  Flexible
Materials  operating  segments.   This  margin  impact   occurred
because  most  of  the Company's manufactured products  are  U.S.
dollar   cost-based  and  sold  in  Europe  generally  in   local
currencies.

The decrease in service gross profit margins was caused primarily
by  a  reclassification of expenses in the Apparel  and  Flexible
Materials operating segment.  This change affected the allocation
of  expenses between warranty, installation, and training and the
fulfillment  of  service contract obligations.  The  decrease  in
this  segment's North American service business noted above  also
was a factor in the margin decline.

S,G,&A expenses, including goodwill amortization, increased  $0.9
million  (2.5  percent) in the first quarter  compared  with  the

<PAGE 13>

prior  year.  The  increase  was  caused  predominantly  by   the
additional  expenses associated with the businesses  acquired  in
the  Sign  Making and Specialty Graphics operating  segment  last
year.    As  a  percentage of sales, S,G,&A  expenses,  including
goodwill  amortization, increased to 27.6 percent in this  year's
first quarter from 26.7 percent last year.

R&D  spending decreased $0.8 million (9.8 percent) in  the  first
quarter  compared with last year's first quarter.   The  decrease
was  caused by the comparatively higher level of expenses related
to new product introductions in last year's first quarter in each
of  the  Company's operating segments.  As a percentage of sales,
research  and  development was 5.6 percent in the  first  quarter
compared  with 6.2 percent last year.  In addition to the  higher
spending last year, the growth in the revenue base resulting from
last  year's  business  acquisitions  in  the  Sign  Making   and
Specialty  Graphics  operating  segment  ($6.2  million   higher)
contributed  to  the  percentage  decrease  in  R&D  because  the
distributor companies purchased do not incur R&D expenses.

In this year's first quarter, the Company recorded a $4.4 million
pre-tax charge that consisted of provisions for severance of $1.9
million, provisions for losses on the sale of facilities of  $2.3
million, and $0.2 million for other asset impairments. See Note 3
on  page  6  of  this quarterly report on Form 10-Q  for  further
discussion of this special charge.

Interest  expense increased $0.8 million to $3.3 million  in  the
first  quarter ended July 31, 2000, the result of higher interest
rates and higher debt balances.  Most of the Company's borrowings
were  against  a  $235  million multi-currency  revolving  credit
facility. The interest rate on these borrowings is based  on  the
London  Interbank Offered Rate (LIBOR) for the relevant  currency
and term plus a margin based on the relationship of the Company's
consolidated  total  debt  to  EBITDA  over  the  trailing   four
quarters.   The  lower  EBITDA realized by the  Company  in  last
year's  fourth quarter and this year's first quarter  has  caused
this  debt  to  EBITDA relationship to rise, and accordingly  the
interest  margin  over  LIBOR to rise.  In anticipation  of  this
higher  debt to EBITDA relationship, the Company was required  to
renegotiate  certain  debt  covenants  in  its  syndicated   bank
agreement,  the effect of which will also increase  the  interest
margin over LIBOR. Accordingly, management believes that interest
expense  will  trend  higher until the full impact  of  its  cost
reduction   and   working   capital  improvement   programs   are
implemented and the debt to EBITDA relationship improves.

The  provision (benefit) rate for income taxes was  35.8  percent
for  the  three  months ended July 31, 2000  compared  with  35.2
percent in the comparable prior year period and 33.6 percent  for
the  full  prior fiscal year.  The lower tax rate last  year  was
primarily  the  result of tax reduction strategies involving  the
Company's wholly owned foreign subsidiaries.

<PAGE 14>

As  a  result  of  the above, net earnings in this  year's  first
quarter  were  $0.1 million or $.01 diluted earnings  per  share,
before  the  special  charge of $4.4 million  ($.13  per  diluted
share)  and  a  net loss of $2.7 million or $.12  per  share  was
realized  after  the  special charge.   Net  earnings  were  $7.6
million  or $.34 diluted earnings per share in last year's  first
quarter.

NEW ACCOUNTING PRONOUNCEMENT

In  June  1998, the Financial Accounting Standards  Board  (FASB)
issued  Statement  of  Financial Accounting  Standards  No.  133,
"Accounting  for  Derivative Instruments and Hedging  Activities"
(SFAS 133) which, as amended, is currently effective May 1, 2001,
for  the Company.  The timing of adoption and the effect of  SFAS
133  on the Company's financial position or results of operations
have not yet been determined.

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains statements which, to the extent
they are not statements of historical or present fact, constitute
"forward-looking  statements" under the  securities  laws.   From
time to time, oral or written forward-looking statements may also
be  included  in  other materials released to the  public.  These
forward-looking  statements are intended to provide  management's
current  expectations  or  plans for  the  future  operating  and
financial  performance  of  the  Company,  based  on  assumptions
currently  believed to be valid.  Forward-looking statements  can
be  identified  by the use of words such as "believe,"  "expect,"
"plans,"    "strategy,"   "prospects,"   "estimate,"   "project,"
"anticipate,"  and other words of similar meaning  in  connection
with  a  discussion of future operating or financial performance.
These include, among others, statements relating to:

-    future   earnings  and  other  measurements   of   financial
     performance,
-    future cash flow and uses of cash,
-    the  effect  of  economic downturns or growth in  particular
     regions,
-    the effect of changes in the level of activity in particular
     industries or markets,
-    the scope or nature of acquisition activity,
-    prospective   product   developments   and   new    business
     opportunities,
-    cost reduction efforts,
-    the outcome of contingencies, and
-    the transition to the use of the euro as a currency.

All  forward-looking statements involve risks  and  uncertainties
that  may  cause actual results to differ materially  from  those
expressed  or  implied  in the forward-looking  statements.   For
additional information identifying factors that may cause  actual
results  to  vary  materially from those stated in  the  forward-

<PAGE 15>

looking statements, see the Company's reports on Forms 10-K,  10-
Q, and 8-K filed with the Securities and Exchange Commission from
time to time. The Company's Annual Report on Form 10-K for fiscal
2000  includes  important information as to risk factors  in  the
"Business"  section under the headings "Operating  Segments"  and
"Other  Matters  Relating  to  the Corporation's  Business  as  a
Whole."

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES
         ABOUT MARKET RISK

No  material  changes  have  occurred  in  the  quantitative  and
qualitative  market risk disclosures for the Company  from  those
presented  in  the Company's Annual Report on Form 10-K  for  the
year ended April 30, 2000.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On  August  31,  2000,  the Company held its  annual  meeting  of
shareholders.  The holders of 76 percent of the shares of  common
stock  entitled  to vote at this meeting were present  either  in
person  or  by proxy.  The following were the voting results  for
the meeting:

-     The  shareholders elected Directors to  hold  office  until
the  annual  meeting  to  be  held in  the  year  2003  with  the
following votes:

                                           For        Withheld

     Edward E. Hood, Jr.                 16,216,423      373,508
     William Jerome Vereen               16,225,162      364,769
     Michael J. Cheshire                 16,212,330      377,601

      The  terms  of  office of the other Directors,  Donald  P.
Aiken,  George M. Gentile, David J. Gerber, David  J.     Logan,
Carole F. St. Mark and A. Robert Towbin, continued     after the
meeting.


ITEM 5.  OTHER INFORMATION

On  August 31, 2000, the Company issued a press release reporting
that  its Board of Directors had authorized the Company to pursue
strategic   alternatives  for  its  Ophthalmic  Lens   Processing
operating  segment,  including the potential divestiture  of  the
segment.   The Company also indicated it had no plans  to  divest
any of its other businesses.

<PAGE 16>

                   PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits

     (10)*       First   Amendment   to   $235,000,000   Credit
                 Agreement  Dated  as of May 15,  1998  between
                 Gerber  Scientific, Inc. and the Banks  Listed
                 Herein and Wachovia Bank, N.A.
     (15)*       Letter  regarding unaudited interim  financial
                 information.
     (27)*       Financial data schedule.


(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.



*Filed herewith.

<PAGE 17>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   September 13, 2000  By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)

<PAGE 18>

                          EXHIBIT INDEX




  Exhibit
   Index                                                     Page
  Number                                                     ----
 --------
   (10)*       First   Amendment  to  $235,000,000   Credit
               Agreement  Dated as of May 15, 1998  between
               Gerber Scientific, Inc. and the Banks Listed
               Herein and Wachovia Bank, N.A.
   (15)*       Letter regarding unaudited interim financial
               information.
   (27)*       Financial data schedule.






*Filed herewith.